Liver transaminase after starting or changing lipid-lowering treatment

at 2 to 3 months after starting or changing lipid-lowering treatment

tests per year, UK, at 2 to 3 months after starting or changing treatment, and at 12 months

“Measure liver transaminase and full lipid profile at 2 to 3 months after starting or changing lipid-lowering treatment. ... Measure liver transaminase at 12 months, but not again unless clinically indicated.”

NICE NG238, Cardiovascular disease: risk assessment and reduction, including lipid modification, annual medication review, 2023-12

Kind of source
Clinical guideline
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
Applies to people on lipid-lowering treatment, including secondary prevention after coronary events. The guideline gives no tests-per-year figure.

Used in

Kept as evidence; no figure on the platform is computed from it yet.